Finally, a recent study identified the cell cycle regulator CDK1 as a key promoter of early cystogenesis in ADPKD, and crucially demonstrated that genetic ablation of this gene inhibited cell cycle progression and ameliorated kidney disease phenotypes in vivo (Zhang et al., 2021). The gene discussed is CDK1; the disease is kidney disorder.